Contact
Please use this form to send email to PR contact of this press release:
Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide
TO:
Please use this form to send email to PR contact of this press release:
Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide
TO: